BCM
GBT

Bayesian Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bayesian Capital Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,600
Closed -$610K – 1192
2022
Q1 		$610K Buy
+17,600
New +$610K 0.09% 329